A Charitable Evening Benefiting the National MS Society
Nearly one million Americans are living with multiple sclerosis — a chronic disease of the central nervous system with no known cure. The National MS Society funds cutting-edge research into disease-modifying therapies, myelin repair, and neuroprotection, while providing direct services to patients and families navigating the disease today.
Every ticket to the Manhattan Solstice Gala goes directly toward that work. This is an evening with a specific purpose: to move the needle on one of medicine's most complex and underfunded challenges.
One seat at the Gala on June 13, 2026. Includes entry, open bar, and hors d'oeuvres. Full evening program at Hudson Room · City Winery, 7–10 PM.
If you feel so inclined, we welcome an additional contribution to benefit the National MS Society.Secure checkout via Stripe · All proceeds benefit National MS Society
Multiple sclerosis is a chronic disease of the central nervous system in which the immune system attacks the protective myelin sheath surrounding nerve fibers — disrupting the signals between the brain and the rest of the body.
The result can be anything from numbness and vision problems to paralysis and cognitive difficulty. MS is unpredictable. It affects each person differently. It can relapse and remit, or steadily progress. There is no known cure.
Most people are diagnosed between the ages of 20 and 50 — often in the prime of their personal and professional lives. The disease does not discriminate by background, profession, or aspiration. It simply arrives.
Founded in 1946, the National MS Society is the world's largest funder of MS research. Through advocacy, education, and direct support, they are relentlessly moving toward a world free of MS.
The Society funds hundreds of research grants annually, driving discoveries in myelin repair, neuroprotection, and next-generation disease-modifying therapies.
Programs like MS Navigator connect people with MS to local resources, financial assistance, and peer support — ensuring no one faces the disease alone.
The Society advocates at federal and state levels for policies that protect access to care, disability rights, and accelerated pathways for new MS treatments.